Western Pacific Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
Western Pacific Wealth Management's XBI Position: Q3 2022 in Review
Western Pacific Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 1,000 shares — an estimated $74K sold.
Western Pacific Wealth Management first reported a position in XBI in Q4 2021 and held it in 3 quarters. The position peaked at $74K in Q2 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.
- Western Pacific Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
- Western Pacific Wealth Management sold 1,000 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $74K.
- Western Pacific Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 3 quarters.
- Western Pacific Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $74K in Q2 2022.
- 704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.
Based on Western Pacific Wealth Management's 13F filing for Q3 2022, filed 27 Oct 2022.